Stock

Ecolab Inc. (ECL)

NYSE · Basic Materials · Chemicals - Specialty

Profile

Ecolab Inc.

Exchange
NYSE
Ticker
ECL
Sector
Basic Materials
Industry
Chemicals - Specialty
Country
US

Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through four segments: Global Water, Global Institutional & Specialty, Global Pest Elimination, and Global Life Sciences. The Global Water segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, primary metals and mining, power generation, global refining, petrochemical, pulp and paper industries. The Global Institutional & Specialty segment provides cleaning and sanitizing products to the foodservice, healthcare, hospitality, lodging, government, education and retail industries. The Global Pest Elimination segment provides pest elimination services to detect, prevent, and eliminate pests comprising rodents and insects in full-service and quick-service restaurants, food and beverage processors, hotels, grocery operations, and other commercial segments, including education, life sciences, and healthcare. The Global Life Sciences segment provides cleaning and contamination control solutions to pharmaceutical and personal care manufacturers. It offers its products under the Ecolab, Kay, Purolite, and Bioquell brand names. The company sells its products through field sales and corporate account personnel, distributors, and dealers. Ecolab Inc. was founded in 1923 and is headquartered in Saint Paul, Minnesota.

Key facts

Ecolab Inc.: key facts

  • Ecolab Inc. (NYSE: ECL) is a Chemicals - Specialty company in the Basic Materials sector.
  • In fiscal 2025, Ecolab Inc. reported revenue of $16.1B and net income of $2.1B.
  • Revenue grew 6.0% a year over the last 4 fiscal years.
  • Free cash flow was positive in 5 of the last 5 fiscal years.
  • Net income was positive in 5 of the last 5 fiscal years.
  • Over the last twelve months, revenue was $17.4B and net income was $2.1B.

MonkScore

Ecolab Inc.'s MonkScore

MonkScore

MonkScore range: 80–90

as of October 2026

Sector rank: 117 of 616 in Basic Materials

How this score is madeDisclaimer

Pillar ranges

  • Growth80–90
  • Profitability70–80
  • Quality30–40
  • Market Conviction90–100
  • Safety10–20

The MonkScore runs from 0 to 100. Each range is one of ten 10-point groups, from 0–10 to 90–100.

Each pillar's range uses the same ten groups. The exact score and the pillar scores are in the MonkStreet app.

Fundamentals

Figures from the statements

Ecolab Inc.'s annual figures and the last twelve months, in USD. Last report: 30 September 2026.

FigureLast 12 monthsFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$17.4B$16.1B$15.7B$15.3B$14.2B$12.7B
Gross profit$7.6B$7.2B$6.8B$6.2B$5.4B$5.2B
Operating income$3.0B$2.9B$2.6B$2.2B$1.6B$1.7B
Net income$2.1B$2.1B$2.1B$1.4B$1.1B$1.1B
Operating cash flow$3.0B$3.0B$2.8B$2.4B$1.8B$2.1B
Capital expenditure-$1.2B-$1.0B-$994.5M-$774.8M-$712.8M-$643.0M
Free cash flow$1.8B$1.9B$1.8B$1.6B$1.1B$1.4B
Total debt$13.8B$9.4B$8.3B$8.7B$9.0B$9.2B
Cash$722.3M$646.2M$1.3B$919.5M$598.6M$359.9M

Revenue growth a year

1-year
2.2%
3-year
4.3%
4-year
6.0%

Compound growth between fiscal years.

Peers

Similar companies

  • NewMarket CorporationNYSE:NEUMonkScore range: 80–90
  • RPM International Inc.NYSE:RPMMonkScore range: 80–90
  • Balchem CorpNASDAQ:BCPCMonkScore range: 80–90
  • Oil-Dri Corporation of AmericaNYSE:ODCMonkScore range: 90–100
  • Hawkins, Inc.NASDAQ:HWKNMonkScore range: 90–100
  • Ingevity CorporationNYSE:NGVTMonkScore range: 90–100
  • The Sherwin-Williams CompanyNYSE:SHWMonkScore range: 90–100
  • WD-40 CompanyNASDAQ:WDFCMonkScore range: 90–100

Compare

Compare with

See the full analysisEcolab Inc.'s exact MonkScore and pillar scores, in the MonkStreet app

Score my top stocks · 14-day free trial · card required · not charged during the trial · cancel in one click

MonkStreet provides research, not investment advice.

Page built on 31 October 2026.